Perhaps not a variety- that was never suggested . but specific cancer types with a family history for an annual check up. If magsense or MRI using the np offers the benefit of non toxicity early detection - a fraction of the number of cancer cells than which MRI 1.0 can pick up. = early detection.
Obviously as stated they are starting with just a few , HER2 breast / ovarian/ prostate etc and will grow diversified testing bit by bit requiring specific antibodies
The potential for Siemens MRI to include this as the preferred contrast agent for early detection .
When it has a clear marketing advantages over other suppliers who don’t have access to our IP.
Buy hold or sell. You really just need to ask what are Siemens going to do with successful trials.
the company has clearly stated the potential of Siemens = alternate commercial path
imo - Siemens will takeover this company on success trials . The marketing advantages to them for exclusive access to the IP.
- Forums
- ASX - By Stock
- IBX
- Interesting
IBX
imagion biosystems limited
Add to My Watchlist
6.25%
!
1.7¢

Interesting, page-1148
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $3.422M |
Open | High | Low | Value | Volume |
1.7¢ | 1.7¢ | 1.7¢ | $28.90K | 1.710M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 2766160 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 11290 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 2766160 | 0.016 |
14 | 1979004 | 0.015 |
10 | 2803876 | 0.014 |
12 | 1402142 | 0.013 |
21 | 5025863 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 874048 | 9 |
0.019 | 3009109 | 10 |
0.020 | 2419161 | 13 |
0.021 | 1858857 | 4 |
0.022 | 901175 | 6 |
Last trade - 15.59pm 23/07/2025 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |